MagGel-BS platform addresses challenges related to the targeted delivery and subsequent recovery of engineered bacteria within the GI tract.
Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.
PERT edits the genome to permanently express a suppressor tRNA, so that cells affected by nonsense mutations can produce functional protein.
The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback